AAREY DRUGS & PHARMACEUTICALS
|
The Current P/E Ratio of AAREY DRUGS & PHARMACEUTICALS is 73.42.
| Share Price | ₹99.2 | Sep 11,2026 |
| Market Cap | ₹306.6 Cr | |
| Earnings-TTM | ₹4.2 Cr | TTM-Standalone Results |
| Price/Earnings | 73.42x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of AAREY DRUGS & PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹306.6 Cr] as on Sep 11,2026
(/) Earnings [ ₹4.2 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 73.42x ]
Thus, for AAREY DRUGS & PHARMACEUTICALS , the investors are currently willing to pay 73.42 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of AAREY DRUGS & PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of AAREY DRUGS & PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of AAREY DRUGS & PHARMACEUTICALS
PE Ratio Performance Analysis for AAREY DRUGS & PHARMACEUTICALS
- AAREY DRUGS & PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 18.18x.
- AAREY DRUGS & PHARMACEUTICALS 's operated at median p/e ratio of 16.03x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AAREY DRUGS & PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 26.76x.
- AAREY DRUGS & PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 8.33x.
How does AAREY DRUGS & PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?
| Peer Comparison (Trading Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| AAREY DRUGS & PHARMACEUTICALS | 4.18 | 73.42 | 306.6 |
| ADANI ENTERPRISES LTD | 7,230.06 | 57.24 | 413,847.0 |
| PREMIER ENERGIES LTD | 1,668.39 | 26.52 | 44,239.8 |
| ADITYA INFOTECH LTD | 477.28 | 94.93 | 45,310.8 |
| AEGIS LOGISTICS LTD | 1,476.11 | 32.17 | 47,493.8 |
| REDINGTON LTD | 1,504.66 | 20.45 | 30,774.6 |
| RRP SEMICONDUCTOR LTD | -7.80 | -1,463.64 | 11,409.1 |
| HONASA CONSUMER LTD | 249.40 | 61.56 | 15,354.1 |
| LLOYDS ENTERPRISES LTD | 235.77 | 45.19 | 10,653.8 |
| MMTC LTD | 269.13 | 34.53 | 9,294.0 |
| CELLO WORLD LTD | 324.26 | 23.16 | 7,510.4 |
Trading Industry Benchmark (Top 10) PE Analysis vs AAREY DRUGS & PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -1,463.64x |
| Max industry PE | 94.93x |
| Median industry PE | 34.53x |
| Average industry PE | -90.41x |
You may also like the below Video Courses